KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insulet (PODD) Other financing activities (2010 - 2020)

Insulet posted quarterly Other financing activities of $500000.0 for Q4 2020, up 153.42% on a QoQ basis from -$936000.0 in Q4 2010.

Insulet (PODD) has 2 years of Other financing activities data on file, last reported at $500000.0 in Q4 2020.

  • For the quarter ending Q4 2020, Other financing activities changed N/A year-over-year to $500000.0; the trailing twelve-month figure through Sep 2022 stood at $500000.0 (up 214.68% YoY), and the FY2023 full-year result was -$300000.0, changed N/A from the prior year.
  • Other financing activities for Q4 2020 stood at $500000.0, up from -$936000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $500000.0 in Q4 2020 and bottomed at $500000.0 in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2020 500,000.00
Dec 31, 2020 500,000.00
Dec 31, 2010 -936,000.00
Dec 31, 2010 -936,000.00